Cellectis (CLLS) Return on Equity [ROE] (2015 - 2026)
Cellectis (CLLS) reported Return on Equity [ROE] of -99.54% for Q2 2026, down 44.22 percentage points from -55.32% a year earlier and down 13.76 percentage points from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Cellectis posted Return on Equity [ROE] of -65.33%, down 31.25 percentage points from FY2024.
- Return on Equity [ROE] has a five-year change of -51.26 percentage points (FY2020 to FY2025).
- By year, Return on Equity [ROE] came in at -34.08% in FY2024 (+68.89 pp), -102.97% in FY2023 (-40.04 pp), -62.93% in FY2022 (-17.05 pp) and -45.88% in FY2021 (-31.81 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] since Q4 2023.
- Year over year, Return on Equity [ROE] has now declined in each of the last three quarters, with an average year-over-year change of +11.70 percentage points over the last eight quarters.
- The high point for year-over-year Return on Equity [ROE] in five years was Q4 2024 (a gain of 106.64 percentage points); the low point was Q1 2022 (a drop of 53.04 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -85.77% (Q1 2026), -76.65% (Q4 2025) and -35.78% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Cellectis | 143.49 Mn | -609.91 Mn | - | -99.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -99.54% |
| Mar 31, 2026 | -85.77% |
| Dec 31, 2025 | -76.65% |
| Sep 30, 2025 | -35.78% |
| Jun 30, 2025 | -55.32% |
| Mar 31, 2025 | -48.97% |
| Dec 31, 2024 | -28.23% |
| Sep 30, 2024 | -60.77% |
| Jun 30, 2024 | -65.98% |
| Mar 31, 2024 | -80.19% |
| Dec 31, 2023 | -134.86% |
| Sep 30, 2023 | -110.27% |
| Jun 30, 2023 | -100.43% |
| Mar 31, 2023 | -90.74% |
| Dec 31, 2022 | -83.99% |
| Sep 30, 2022 | -69.64% |
| Jun 30, 2022 | -63.80% |
| Mar 31, 2022 | -65.76% |
| Dec 31, 2021 | -50.18% |
| Sep 30, 2021 | -18.70% |
API Access
Cellectis Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();